Application of bioimpedance spectroscopy in Asian dialysis patients (ABISAD-III): a randomized controlled trial for clinical outcomes

被引：36

作者：

Chen Huan-Sheng ^{[1
]}

Chang Yeong-Chang ^{[2
]}

Hsieh Ming-Hsing ^{[3
]}

Tseng Fan-Lieh ^{[3
]}

Lin Chu-Cheng ^{[4
]}

Wu Tsai-Kun ^{[5
]}

Chen Hung-Ping ^{[5
]}

Hung Sze-Hung ^{[6
]}

Chiu Hsien-Chang ^{[7
]}

Lee Chia-Chen ^{[2
]}

Hou Chun-Cheng ^{[8
]}

Cheng Chun-Ting ^{[9
]}

Liou Hung-Hsiang ^{[10
]}

Lin Chun-Ju ^{[11
]}

Lim Paik-Seong ^{[5
]}

机构：

[1] An Hsin QingShui Clin, Taichung, Taiwan

[2] Sheng An Clin, Yunlin, Taiwan

[3] Fu Ping Hosp, Dialysis Ctr, Taichung, Taiwan

[4] Yuan Lin Hos Hosp, Dialysis Ctr, Changhua, Taiwan

[5] Tungs Taichung MetroHarbor Hosp, Dept Nephrol, 699,Sec 1,Chungchi Rd, Taichung 43503, Taiwan

[6] Tseng Han Chi Hosp, Dialysis Ctr, Nantou, Taiwan

[7] An Hsin Chushan Clin, Nantou, Taiwan

[8] Min Sheng Gen Hosp, Dept Nephrol, Taoyuan, Taiwan

[9] St Pauls Hosp, Dept Nephrol, Taoyuan, Taiwan

[10] Hsin Jen Hosp, Dialysis Ctr, Taipei, Taiwan

[11] China Med Univ, Sch Med, Taichung, Taiwan

来源：

INTERNATIONAL UROLOGY AND NEPHROLOGY | 2016年 / 48卷 / 11期

关键词：

Bioimpedance spectroscopy; Body composition monitor; Hemodialysis; Intra-dialysis morbidities; LEFT-VENTRICULAR HYPERTROPHY; BODY-COMPOSITION MONITOR; GUIDED FLUID MANAGEMENT; LONG-TERM SURVIVAL; HEMODIALYSIS-PATIENTS; DRY-WEIGHT; MAINTENANCE HEMODIALYSIS; BLOOD-PRESSURE; VOLUME CONTROL; MORTALITY;

D O I：

10.1007/s11255-016-1415-8

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Fluid management with body composition monitor based on bioimpedance spectroscopy (BCM-BIS) has been found to be beneficial for dialysis patients. We conducted a study to provide an algorithm for the determination of post-dialysis target weight (PDTW) and to evaluate whether this approach could improve clinical outcomes compared to patients who had PDTW decided clinically. Two hundred and ninety-eight dialysis patients participated in this 1-year randomized controlled trial. The outcomes were all-cause hospitalization rate, AFO or CV-related events, hypertension and intra-dialysis morbidities. 80 % of post-dialysis weight reached the target set with current algorithm. All-cause hospitalization rate was not different. Incidence of acute fluid overload (AFO) or CV-related events was lower in study group. Longitudinal data showed decreased incidence of hypertension, intra-dialysis morbidities and intra-dialysis hypotension. Assessment of PDTW by BCM-BIS with an explicit algorithm decreased AFO or CV-related events, hypertension and intra-dialysis morbidities. Further studies were required to demonstrate possible benefits of hospitalization rate.

引用

页码：1897 / 1909

页数：13